AMN HEALTHCARE SERVICES INC — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
AMN Healthcare reported Q2 2026 revenue of $673.2 million, up 2% year-over-year, with adjusted EBITDA of $73.4 million (up 26% YoY) and adjusted diluted EPS of $0.77 (up 158% YoY). The company returned $494 million in client deposits related to Q1 labor disruption events, reducing Q2 cash flow by ($190) million. Q3 2026 guidance calls for $640–$655 million revenue (1–3% YoY growth). Cash position at quarter-end was $362 million with leverage ratio of 1.5x.
Why this rating
Q2 beat guidance but full-year trajectory remains weak; modest YoY growth and declining guidance offset by improving adjusted metrics and strong cash recovery from labor disruptions. Leverage improved sharply. Material but within normal operating range for this ~$788M market-cap company.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.